alexa Sialosylgalactosylceramide (GM4) is a major ganglioside in chicken embryonic liver.


Journal of Glycobiology

Author(s): Saito M, Rosenberg A

Abstract Share this page

Abstract The developmental changes in gangliosides of chicken liver were investigated during embryonic and neonatal life. Sialosylgalactosylceramide (GM4) and sialosyllactosylceramide (GM3) were major gangliosides during the entire period investigated. Sialosylgalactosylceramide (GM4) was detected as the predominant species until 2 days before hatching and then GM3 increased to be the major sialoglycolipid. GM4 continued to be detectable until at least 2 weeks after hatching. Monogalactosylceramide was detected as the major neutral glycolipid. The fatty acids obtained from monogalactosylceramide showed a similar pattern to that of GM4.
This article was published in J Lipid Res and referenced in Journal of Glycobiology

Relevant Expert PPTs

Recommended Conferences

  • International Conference on Glycobiology
    Sep 21-22, 2017, Crowne Plaza Houston River Oaks, Houston, USA
  • 2nd International Conference on Biochemistry
    Sep 21-22, 2017 Macau, Hong Kong
  • International Conference on Glycobiology
    Oct 02-04, 2017 Atlanta, USA
  • 4th International Conference on Glycobiology and Glycochemistry
    July 16-18, 2018 Melbourne, Australia
  • 4th Glycobiology World Congress
    September 17-19, 2018 Rome, Italy
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version